| 中文名 | 乳-N-新四糖 |
|---|---|
| 英文名 | β-D-Gal-(1→4)-β-D-GlcNAc-(1→3)-β-D-Gal-(1→4)-D-Glc |
| 中文别名 |
乳-N-新四糖(2型链)
N-((2S,3R,4R,5S,6R)-2-(((2R,3S,4S,5R,6S)-3,5-二羟基-2-(羟甲基)-6-(((2R,3R,4R,5R)-1,2,4,5-四羟基-6-氧代己烷-3-基)氧基)四氢-2H-吡喃-4-基)氧基)-4-羟基-6-(羟甲基-5-(((2S,3R,4S,5R,6R)-3,4,5-三羟基-6-(羟甲基)四氢-2H-吡喃-2-基)氧基)四氢-2H-吡喃-3-基)乙酰胺 乳糖-N-新四糖(2型链) 乳-N-四糖(I型链)/乳-N-新四糖(II型链)混合物 乳果糖杂质26 乳糖-N-新四糖 / 核心结构类型2(LNnT/ neoLNT) 乳糖-N-新四糖LNNT |
| 英文别名 |
Lacto-N-neotetraose (LNnT / neo-LNT)
lacto-N-neo-tetraose from human milk Lacto-N-neotetraose (LNnT / neo-LNT) linked to biotin (Linker-BT C) Lacto-N-neotetraose (LNnT / neo-LNT) afted on gel for affinity chromatoaphy (Linker-GEL A) N-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3R,4R,5R)-1,2,4,5-tetrahydroxy-6-oxohexan-3-yl]oxyoxan-4-yl]oxy-4-hydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide LACTO-N-NEOTETRAOSE Lacto-N-neotetraose (LNnT / neo-LNT) linked to fluorescein (Linker-FLUO A) NLCOSE4 NLCOSE Lacto-N-neotetraose (LNnT / neo-LNT) with cyclic di-thiol (Linker-LIPO A) N-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-4-yl]oxy-4-hydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide Lacto-N-neotetraose (LNnT / neo-LNT) with terminal alkyne (Linker-CΞCH C) Lacto-N-neotetraose (LNnT / neo-LNT) afted on KLH Neolactotetraose Lacto-N-neotetraose (LNnT / neo-LNT) linked to biotin and fluorescein (Linker-BT-FLUO A) Lacto-N-neotetraose (LNnT / neo-LNT) with free terminal amine (Linker-NH2 D) Lacto-N-neotetraose (LNnT / neo-LNT) with customizable dual functionalization LNnT, β-D-Gal-β-D-GlcNAc-β-D-Gal-D-Glc Lacto-N-neotetraose (LNnT / neo-LNT) afted on HSA Lacto-N-neotetraose (LNnT / neo-LNT) afted on BSA Lacto-N-neotetraose (LNnT / neo-LNT) afted on CRM197 Lacto-N-neotetraose (LNnT / neo-LNT) linked to biotin (Linker-BT A) Lacto-N-neotetraose (LNnT / neo-LNT) with terminal alkyne (Linker-CΞCH B) Lacto-N-neotetraose (LNnT / neo-LNT) with free terminal amine (Linker-NH2 C) Lactulose Impurity 26 Lacto-N-neotetraose (LNnT / neo-LNT) Analytical Reference Lacto-N-neotetraose (LNnT / neo-LNT) linked to maleimide (Linker-MAL A) BETA-D-GAL-[1-]-BETA-D-GLCNAC-[1-]-BETA-D-GAL-[1-]-D-GLC Lacto-N-neotetraose (LNnT / neo-LNT) with terminal azide (Linker-N3 B) Lacto-N-neo-tetraose beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-Glc LNT/LNnT-mix[lacto-N-tetraose (type I chain)/lacto-N-neotetraose (type II chain) Lacto-N-neotetraose (LNnT / neo-LNT) linked to biotin and steic chain (Linker-BT-STEA A) Lacto-N-neotetraose (LNnT / neo-LNT) with DBCO (Linker-DBCO A) Lacto-N-neotetraose (LNnT / neo-LNT) linked to desthiobiotin (Linker-DBT-A) Lacto-N-neotetraose (LNnT / neo-LNT) linked to biotin (Linker-BT B) Lacto-N-neotetraose (LNnT / neo-LNT) afted on OVA Lacto-N-neotetraose (LNnT / neo-LNT) with free terminal amine (Linker-NH2 B) Lacto-N-neotetraose (LNnT / neo-LNT) with terminal alkyne (Linker-CΞCH A) D-Glucose, O-β-D-galactopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4) Lacto-N-neotetraose (LNnT / neo-LNT) ( HPLC) Lacto-N-neotetraose (LNnT / neo-LNT) with steic chain (Linker-STEA A) Lacto-N-neotetraose ,>= Lacto-N-neotetraose / Core structure type 2(LNnT/ neoLNT) Lacto-N-neotetraose (LNnT / neo-LNT) afted on gel for affinity chromatoaphy (Linker-GEL B) Lacto-N-neotetraose (LNnT / neo-LNT) with terminal azide (Linker-N3 A) GAL-BETA1,4GLCNA-CBETA1, 3GAL-BETA1, 4GLC N-((2S,3R,4R,5S,6R)-2-(((2R,3S,4S,5R,6S)-3,5-Dihydroxy-2-(hydroxymethyl)-6-(((2R,3R,4R,5R)-1,2,4,5-tetrahydroxy-6-oxohexan-3-yl)oxy)tetrahydro-2H-pyran-4-yl)oxy)-4-hydroxy-6-(hydroxymethyl)-5-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-3-yl)acetamide Galβ1,4GlcNAcβ1,3Galβ1,4Glc Lacto-N-neotetraose (LNnT / neo-LNT) with free terminal amine (Linker-NH2 A) Hydrochloride form |
| 描述 | 乳糖-N-新四糖(LNnT)是一种内源性代谢物。乳糖-N-新四糖可抑制TNF-α诱导的未成熟上皮细胞分泌IL-8。乳糖-N-新四糖具有抗炎活性,可以改善伤口闭合[1][2][4]。 |
|---|---|
| 相关类别 | |
| 靶点 |
Endogenous Metabolite[1], TNFR1[2]. |
| 体外研究 | 乳糖-N-新四糖(5 mg/mL,24 h)诱导T84细胞分泌IL-8[2]。乳糖-N-新四糖(5 mg/mL,24 h)可减少TNF-α诱导的FHs 74 Int细胞IL-8分泌,其减少率为38%[2]。乳糖-N-新四糖以900±660 nM的Kd值结合TNFR1(肿瘤坏死因子受体1)[2]。乳糖-N-新四糖(5 mg/mL,24 h)通过FHs 74 Int细胞中TNFR1外结构域的脱落减轻TNF-α诱导的炎症[2]。 |
| 体内研究 | 乳糖-N-新四糖(100μM,气管内给药24小时)可减少肺炎兔肺部肺炎链球菌的数量[3]。乳糖-N-新四糖(100/200μg,皮内注射,术后第3、7、14和21天)可提高创伤后第7天的伤口闭合率[4]。动物模型:肺炎兔模型[3]剂量:100μM给药:气管内给药24小时结果:激发48小时后肺部细菌负荷下降约2 logs。消除了对照动物在48小时时明显的广泛水肿性右中叶病变。动物模型:对称全厚伤口小鼠剂量:100、200μg给药:术后3、7、14和21天皮内注射。结果:愈合评分、毛囊形成和表皮厚度指数(H&E染色)均较好。 |
| 参考文献 |
| 密度 | 1.72g/cm3 |
|---|---|
| 沸点 | 1173.6ºC at 760mmHg |
| 分子式 | C26H45NO21 |
| 分子量 | 707.63000 |
| 闪点 | 663.6ºC |
| 精确质量 | 707.24800 |
| PSA | 356.70000 |
| 蒸汽压 | 0mmHg at 25°C |
| 折射率 | 1.668 |
| 储存条件 | 2-8°C |
| 危险品运输编码 | NONH for all modes of transport |
|---|---|
| WGK德国 | 3 |